(CACI) CACI International - Overview
Stock: Cyber, Intelligence, Command, Space, Spectrum
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 28.4% |
| Relative Tail Risk | -13.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.55 |
| Alpha | 54.06 |
| Character TTM | |
|---|---|
| Beta | 0.394 |
| Beta Downside | 0.120 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.88% |
| CAGR/Max DD | 0.64 |
Description: CACI CACI International January 02, 2026
CACI International Inc. (NYSE:CACI) delivers a portfolio of government-focused technology and engineering services across the United States, United Kingdom, Europe, and other international markets. Its core offerings include cyber-defense and offensive capabilities, secure enterprise IT, mission-critical engineering (e.g., platform modernization, naval architecture, training simulators), space-related data analytics, and spectrum-superiority solutions for ISR and electronic warfare.
Key financial and operational metrics (FY 2023) show a revenue base of roughly $6.1 billion, with a 7 % year-over-year growth driven primarily by expanding cyber contracts and increased spending on AI-enabled analytics in the defense sector. The company’s backlog-approximately $9 billion-indicates a multi-year revenue visibility that exceeds its annual sales, a common buffer for defense contractors.
Sector drivers that materially affect CACI’s outlook include: (1) sustained U.S. federal defense budget growth (~3 % CAGR through 2028), (2) heightened demand for cyber resilience across both civilian and military agencies, and (3) accelerating adoption of cloud-native and AI-enhanced solutions in intelligence and logistics, which raise the marginal value of CACI’s digital platforms.
Investors looking for deeper quantitative insight should explore ValueRay’s detailed analyst models, which break out CACI’s segment margins and contract risk profiles for a more granular valuation.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 517.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.09 > 1.0 |
| NWC/Revenue: 11.69% < 20% (prev 6.91%; Δ 4.78% < -1%) |
| CFO/TA 0.08 > 3% & CFO 694.7m > Net Income 517.4m |
| Net Debt (2.54b) to EBITDA (774.4m): 3.28 < 3 |
| Current Ratio: 1.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (22.1m) vs 12m ago -2.00% < -2% |
| Gross Margin: 9.16% > 18% (prev 0.09%; Δ 906.6% > 0.5%) |
| Asset Turnover: 101.9% > 50% (prev 95.13%; Δ 6.82% > 0%) |
| Interest Coverage Ratio: 3.37 > 6 (EBITDA TTM 774.4m / Interest Expense TTM 180.7m) |
Altman Z'' 4.22
| A: 0.12 (Total Current Assets 2.11b - Total Current Liabilities 1.07b) / Total Assets 8.93b |
| B: 0.57 (Retained Earnings 5.11b / Total Assets 8.93b) |
| C: 0.07 (EBIT TTM 609.5m / Avg Total Assets 8.74b) |
| D: 1.07 (Book Value of Equity 5.11b / Total Liabilities 4.80b) |
| Altman-Z'' Score: 4.22 = AA |
Beneish M -3.16
| DSRI: 0.83 (Receivables 1.10b/1.20b, Revenue 8.91b/8.13b) |
| GMI: 0.99 (GM 9.16% / 9.10%) |
| AQI: 0.94 (AQ_t 0.70 / AQ_t-1 0.75) |
| SGI: 1.10 (Revenue 8.91b / 8.13b) |
| TATA: -0.02 (NI 517.4m - CFO 694.7m) / TA 8.93b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of CACI shares?
Over the past week, the price has changed by -0.34%, over one month by +10.56%, over three months by +5.84% and over the past year by +64.82%.
Is CACI a buy, sell or hold?
- StrongBuy: 10
- Buy: 4
- Hold: 1
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CACI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 713.5 | 15.4% |
| Analysts Target Price | 713.5 | 15.4% |
| ValueRay Target Price | 823.6 | 33.2% |
CACI Fundamental Data Overview February 01, 2026
P/E Forward = 21.7865
P/S = 1.5265
P/B = 3.326
P/EG = 3.38
Revenue TTM = 8.91b USD
EBIT TTM = 609.5m USD
EBITDA TTM = 774.4m USD
Long Term Debt = 2.92b USD (from longTermDebt, last quarter)
Short Term Debt = 38.8m USD (from shortLongTermDebt, last quarter)
Debt = 3.34b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 2.54b USD (from netDebt column, last quarter)
Enterprise Value = 16.62b USD (13.71b + Debt 3.34b - CCE 423.0m)
Interest Coverage Ratio = 3.37 (Ebit TTM 609.5m / Interest Expense TTM 180.7m)
EV/FCF = 24.90x (Enterprise Value 16.62b / FCF TTM 667.5m)
FCF Yield = 4.02% (FCF TTM 667.5m / Enterprise Value 16.62b)
FCF Margin = 7.49% (FCF TTM 667.5m / Revenue TTM 8.91b)
Net Margin = 5.81% (Net Income TTM 517.4m / Revenue TTM 8.91b)
Gross Margin = 9.16% ((Revenue TTM 8.91b - Cost of Revenue TTM 8.10b) / Revenue TTM)
Gross Margin QoQ = 9.30% (prev 9.30%)
Tobins Q-Ratio = 1.86 (Enterprise Value 16.62b / Total Assets 8.93b)
Interest Expense / Debt = 1.35% (Interest Expense 45.0m / Debt 3.34b)
Taxrate = 23.32% (37.7m / 161.5m)
NOPAT = 467.4m (EBIT 609.5m * (1 - 23.32%))
Current Ratio = 1.97 (Total Current Assets 2.11b / Total Current Liabilities 1.07b)
Debt / Equity = 0.81 (Debt 3.34b / totalStockholderEquity, last quarter 4.14b)
Debt / EBITDA = 3.28 (Net Debt 2.54b / EBITDA 774.4m)
Debt / FCF = 3.80 (Net Debt 2.54b / FCF TTM 667.5m)
Total Stockholder Equity = 3.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.92% (Net Income 517.4m / Total Assets 8.93b)
RoE = 13.04% (Net Income TTM 517.4m / Total Stockholder Equity 3.97b)
RoCE = 8.84% (EBIT 609.5m / Capital Employed (Equity 3.97b + L.T.Debt 2.92b))
RoIC = 6.79% (NOPAT 467.4m / Invested Capital 6.88b)
WACC = 6.13% (E(13.71b)/V(17.04b) * Re(7.37%) + D(3.34b)/V(17.04b) * Rd(1.35%) * (1-Tc(0.23)))
Discount Rate = 7.37% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.72%
[DCF Debug] Terminal Value 87.53% ; FCFF base≈584.7m ; Y1≈715.0m ; Y5≈1.19b
Fair Price DCF = 1345 (EV 32.25b - Net Debt 2.54b = Equity 29.71b / Shares 22.1m; r=6.13% [WACC]; 5y FCF grow 23.83% → 2.90% )
EPS Correlation: 85.30 | EPS CAGR: 10.77% | SUE: 0.58 | # QB: 0
Revenue Correlation: 97.92 | Revenue CAGR: 9.42% | SUE: -1.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=7.16 | Chg30d=+0.016 | Revisions Net=+1 | Analysts=12
EPS current Year (2026-06-30): EPS=28.72 | Chg30d=+0.476 | Revisions Net=+7 | Growth EPS=+8.5% | Growth Revenue=+9.3%
EPS next Year (2027-06-30): EPS=31.85 | Chg30d=+0.260 | Revisions Net=+4 | Growth EPS=+10.9% | Growth Revenue=+7.4%